Claeys, Marc J <br/><br/>
Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.  [electronic resource] 

 -  European heart journal  Mar 2005 
 - 567-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0195-668X 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehi071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Aspirin--therapeutic use<br/>Clopidogrel<br/>Coronary Angiography<br/>Coronary Disease--diagnostic imaging<br/>Creatine Kinase--blood<br/>Creatine Kinase, MB Form<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Isoenzymes--blood<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Neovascularization, Pathologic<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Premedication<br/>Recurrence<br/>Stents<br/>Survival Rate<br/>Thrombosis--prevention & control<br/>Ticlopidine--analogs & derivatives<br/>Troponin T--blood